284 related articles for article (PubMed ID: 26627497)
21. Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study.
Ruberto G; Bruttini C; Tinelli C; Cavagna L; Bianchi A; Milano G
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2201-2210. PubMed ID: 30151601
[TBL] [Abstract][Full Text] [Related]
22. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
Lyons JS; Severns ML
Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
[TBL] [Abstract][Full Text] [Related]
23. Cystoid macular oedema and epiretinal membrane formation during progression of chloroquine retinopathy after drug cessation.
Kellner S; Weinitz S; Farmand G; Kellner U
Br J Ophthalmol; 2014 Feb; 98(2):200-6. PubMed ID: 24187053
[TBL] [Abstract][Full Text] [Related]
24. Hydroxychloroquine retinopathy: an emerging problem.
Latasiewicz M; Gourier H; Yusuf IH; Luqmani R; Sharma SM; Downes SM
Eye (Lond); 2017 Jun; 31(6):972-976. PubMed ID: 28186509
[TBL] [Abstract][Full Text] [Related]
25. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
Marmor MF; Kellner U; Lai TY; Melles RB; Mieler WF;
Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
[TBL] [Abstract][Full Text] [Related]
26. Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity.
Martínez-Costa L; Victoria Ibañez M; Murcia-Bello C; Epifanio I; Verdejo-Gimeno C; Beltrán-Catalán E; Marco-Ventura P
Can J Ophthalmol; 2013 Oct; 48(5):400-5. PubMed ID: 24093187
[TBL] [Abstract][Full Text] [Related]
27. Microperimetric sensitivity in patients on hydroxychloroquine (Plaquenil) therapy.
Jivrajka RV; Genead MA; McAnany JJ; Chow CC; Mieler WF
Eye (Lond); 2013 Sep; 27(9):1044-52. PubMed ID: 23764990
[TBL] [Abstract][Full Text] [Related]
28. [The ERG contribution in early diagnosis of chloroquine and hydroxychloroquine maculopathy].
Karkanová M; Matusková V; Vlková E; Dosková H; Uhmannová R
Cesk Slov Oftalmol; 2010 Apr; 66(2):62-6. PubMed ID: 20925239
[TBL] [Abstract][Full Text] [Related]
29. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.
Rodriguez-Padilla JA; Hedges TR; Monson B; Srinivasan V; Wojtkowski M; Reichel E; Duker JS; Schuman JS; Fujimoto JG
Arch Ophthalmol; 2007 Jun; 125(6):775-80. PubMed ID: 17562988
[TBL] [Abstract][Full Text] [Related]
30. Clinically evident chloroquine toxicity undetected by multifocal electroretinogram.
Burnett HK; Somani R
Can J Ophthalmol; 2012 Oct; 47(5):e31-3. PubMed ID: 23036562
[No Abstract] [Full Text] [Related]
31. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
[TBL] [Abstract][Full Text] [Related]
32. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
[TBL] [Abstract][Full Text] [Related]
33. Macular toxicity after short-term hydroxychloroquine therapy.
Pasaoglu I; Onmez FE
Indian J Ophthalmol; 2019 Feb; 67(2):289-292. PubMed ID: 30672499
[TBL] [Abstract][Full Text] [Related]
34. Spectral-domain optical coherence tomography as a screening technique for chloroquine and hydroxychloroquine retinal toxicity.
Kahn JB; Haberman ID; Reddy S
Ophthalmic Surg Lasers Imaging; 2011; 42(6):493-7. PubMed ID: 21830746
[TBL] [Abstract][Full Text] [Related]
35. Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss.
Stepien KE; Han DP; Schell J; Godara P; Rha J; Carroll J
Trans Am Ophthalmol Soc; 2009 Dec; 107():28-33. PubMed ID: 20126479
[TBL] [Abstract][Full Text] [Related]
36. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
Maturi RK; Yu M; Weleber RG
Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
[TBL] [Abstract][Full Text] [Related]
37. Screening for chloroquine maculopathy in populations with uncertain reliability in outcomes of automatic visual field testing.
Kunavisarut P; Chavengsaksongkram P; Rothova A; Pathanapitoon K
Indian J Ophthalmol; 2016 Oct; 64(10):710-714. PubMed ID: 27905330
[TBL] [Abstract][Full Text] [Related]
38. [SD-OCT As screening test for hydroxychloroquine retinopathy: The «flying saucer» sign].
Asensio-Sánchez VM
Arch Soc Esp Oftalmol; 2015 Jul; 90(7):338-40. PubMed ID: 25443193
[TBL] [Abstract][Full Text] [Related]
39. [Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses].
Rüther K; Foerster J; Berndt S; Schroeter J
Ophthalmologe; 2007 Oct; 104(10):875-9. PubMed ID: 17653725
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy.
Solberg Y; Dysli C; Möller B; Wolf S; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2165-2172. PubMed ID: 31108547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
